309 related articles for article (PubMed ID: 10828060)
1. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity.
Guerre-Millo M; Gervois P; Raspé E; Madsen L; Poulain P; Derudas B; Herbert JM; Winegar DA; Willson TM; Fruchart JC; Berge RK; Staels B
J Biol Chem; 2000 Jun; 275(22):16638-42. PubMed ID: 10828060
[TBL] [Abstract][Full Text] [Related]
2. A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activity.
Brown PJ; Winegar DA; Plunket KD; Moore LB; Lewis MC; Wilson JG; Sundseth SS; Koble CS; Wu Z; Chapman JM; Lehmann JM; Kliewer SA; Willson TM
J Med Chem; 1999 Sep; 42(19):3785-8. PubMed ID: 10508427
[No Abstract] [Full Text] [Related]
3. Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice.
Jeong S; Yoon M
Exp Mol Med; 2009 Jun; 41(6):397-405. PubMed ID: 19322024
[TBL] [Abstract][Full Text] [Related]
4. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Gervois PP; Poulain P; Derudas B; Peters JM; Gonzalez FJ; Princen HM; Kooistra T; Staels B
Blood; 1999 May; 93(9):2991-8. PubMed ID: 10216095
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat.
Dana SL; Hoener PA; Bilakovics JM; Crombie DL; Ogilvie KM; Kauffman RF; Mukherjee R; Paterniti JR
Metabolism; 2001 Aug; 50(8):963-71. PubMed ID: 11474486
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight.
Chaput E; Saladin R; Silvestre M; Edgar AD
Biochem Biophys Res Commun; 2000 May; 271(2):445-50. PubMed ID: 10799317
[TBL] [Abstract][Full Text] [Related]
7. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.
Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K
Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388
[TBL] [Abstract][Full Text] [Related]
8. Effects of fenofibrate on high-fat diet-induced body weight gain and adiposity in female C57BL/6J mice.
Jeong S; Han M; Lee H; Kim M; Kim J; Nicol CJ; Kim BH; Choi JH; Nam KH; Oh GT; Yoon M
Metabolism; 2004 Oct; 53(10):1284-9. PubMed ID: 15375783
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats.
Lee HJ; Choi SS; Park MK; An YJ; Seo SY; Kim MC; Hong SH; Hwang TH; Kang DY; Garber AJ; Kim DK
Biochem Biophys Res Commun; 2002 Aug; 296(2):293-9. PubMed ID: 12163016
[TBL] [Abstract][Full Text] [Related]
10. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.
Schoonjans K; Peinado-Onsurbe J; Lefebvre AM; Heyman RA; Briggs M; Deeb S; Staels B; Auwerx J
EMBO J; 1996 Oct; 15(19):5336-48. PubMed ID: 8895578
[TBL] [Abstract][Full Text] [Related]
11. High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists.
Wang PR; Guo Q; Ippolito M; Wu M; Milot D; Ventre J; Doebber T; Wright SD; Chao YS
Eur J Pharmacol; 2001 Sep; 427(3):285-93. PubMed ID: 11567659
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
[TBL] [Abstract][Full Text] [Related]
13. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
Laurent D; Gounarides JS; Gao J; Boettcher BR
Diabetes Obes Metab; 2009 Jun; 11(6):632-6. PubMed ID: 19175377
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation.
Koh EH; Kim MS; Park JY; Kim HS; Youn JY; Park HS; Youn JH; Lee KU
Diabetes; 2003 Sep; 52(9):2331-7. PubMed ID: 12941773
[TBL] [Abstract][Full Text] [Related]
15. Fenofibrate Regulates Visceral Obesity and Nonalcoholic Steatohepatitis in Obese Female Ovariectomized C57BL/6J Mice.
Shin Y; Lee M; Lee D; Jang J; Shin SS; Yoon M
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916086
[TBL] [Abstract][Full Text] [Related]
16. AZ 242, a novel PPARalpha/gamma agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats.
Ljung B; Bamberg K; Dahllöf B; Kjellstedt A; Oakes ND; Ostling J; Svensson L; Camejo G
J Lipid Res; 2002 Nov; 43(11):1855-63. PubMed ID: 12401884
[TBL] [Abstract][Full Text] [Related]
17. The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice.
Araki M; Nakagawa Y; Oishi A; Han SI; Wang Y; Kumagai K; Ohno H; Mizunoe Y; Iwasaki H; Sekiya M; Matsuzaka T; Shimano H
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041488
[TBL] [Abstract][Full Text] [Related]
18. Identification of hepatic transcriptional changes in insulin-resistant rats treated with peroxisome proliferator activated receptor-alpha agonists.
Frederiksen KS; Wulf EM; Wassermann K; Sauerberg P; Fleckner J
J Mol Endocrinol; 2003 Jun; 30(3):317-29. PubMed ID: 12790802
[TBL] [Abstract][Full Text] [Related]
19. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Princen HM; Kooistra T
Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
[TBL] [Abstract][Full Text] [Related]
20. Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.
Takei K; Han SI; Murayama Y; Satoh A; Oikawa F; Ohno H; Osaki Y; Matsuzaka T; Sekiya M; Iwasaki H; Yatoh S; Yahagi N; Suzuki H; Yamada N; Nakagawa Y; Shimano H
J Diabetes Investig; 2017 Jul; 8(4):446-452. PubMed ID: 28084058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
